Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on August 11, 2026

11 hours ago

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Indeterminate GlobeNewswire

11 hours ago

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

11 hours ago

Mobia Medical Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

11 hours ago

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Indeterminate GlobeNewswire

11 hours ago

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

12 hours ago

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire

12 hours ago

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire

12 hours ago

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Indeterminate GlobeNewswire

12 hours ago

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire

12 hours ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

12 hours ago

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

12 hours ago

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Indeterminate GlobeNewswire

12 hours ago

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

12 hours ago

ASHA Names 2026 Media Champion Award Recipients

Indeterminate GlobeNewswire

12 hours ago

Rampart Withdraws Appeal of USPTO’s Invalidation Decision

Indeterminate GlobeNewswire

12 hours ago

New Drug to Treat Pancreatic Cancer May Be a “Game Changer” as 10 Intermountain Hospitals Join National Initiative

Indeterminate GlobeNewswire

12 hours ago

Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

Indeterminate GlobeNewswire

12 hours ago

Five Years of Unprecedented Growth: TimelyCare Redefines Student Well-Being

Indeterminate GlobeNewswire

12 hours ago

NovelMed Advances NM5072 for Multiple Ocular Disorders

Indeterminate GlobeNewswire

12 hours ago

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2026

Indeterminate GlobeNewswire